Misoprostol In the Prevention of Postpartum Hemorrhage
DOI:
https://doi.org/10.59675/Keywords:
Misoprostol, Post-Partum Hemorrhage.Abstract
Misoprostol, an E1 prostaglandin analogue, induces uterine contractions. Because of this property, misoprostol has proven effective in preventing and treating postpartum haemorrhage (PPH) resulting from the failure of the uterus to contract fully after delivery. In this study, we tried to demonstrate the efficacy of misoprostol in preventing PPH.
Patients and methods: we collected samples of 500 women who attended Al-Batool Teaching Hospital from July 2022 to January 2023. We collected the information by direct interview through a prepared written questionnaire.
Results: 500 women were enrolled in the study, 4.8% had PPH despite the usage of misoprostol. All of them used the rectal route. We found a significant difference between the fibroid and the PPH (P < 0.001).
Conclusion:There is a significantly lower incidence of PPH in misoprostol intake.
References
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006;108(4):1039-47.
World Health Organization. Maternal mortality: Key facts. Geneva: WHO; 2018. Available from: http://www.who.int/en/newsroom/factsheets/detail/maternal-mortality
World Health Organization. WHO recommendations: Uterotonics for the prevention of postpartum haemorrhage. Geneva: WHO; 2018.
Hobday K, Zwi AB, Homer C, Kirkham R, Hulme J, Wate PZ, et al. Misoprostol for the prevention of postpartum haemorrhage in Mozambique: an analysis of the interface between human rights, maternal health and development. BMC Int Health Hum Rights. 2020;20(1):1-3.
Alfirevic Z, Blum J, Walraven G, Weeks A, Winikoff B. Prevention of postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet. 2007;99(Suppl 2):S198-201.
Raghavan S, Abbas D, Winikoff B. Misoprostol for prevention and treatment of postpartum hemorrhage: What do we know? What is next?. Int J Gynaecol Obstet. 2012;119(Suppl 1):S35-8.
Raghavan S, Abbas D, Winikoff B. Misoprostol for prevention and treatment of postpartum hemorrhage: What do we know? What is next?. Int J Gynaecol Obstet. 2012;119(Suppl 1):S35-8.
Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2007;(3):CD000494.
McDonald S, Prendiville WW, Elbourne D. Prophylactic syntometrine vs oxytocin in the third stage of labour. Cochrane Database Syst Rev. 1996;(4):CD001808.
Chhabra S, Tickoo C. Low-dose sublingual misoprostol versus methylergometrine for active management of the third stage of labor. J Obstet Gynaecol Res. 2008;34(5):820-3.
Vimala N, Mittal S, Kumar S. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section. Int J Gynaecol Obstet. 2006;92(2):106-10.
Mansouri HA, Alsahly N. Rectal versus oral misoprostol for active management of third stage of labor: a randomized controlled trial. Arch Gynecol Obstet. 2011;283(5):935-9.
Mirteimouri M, Tara F, Teimouri B, Sakhavar N, Vaezi A. Efficacy of rectal misoprostol for prevention of postpartum hemorrhage. Iran J Pharm Res. 2013;12(2):469-73.
Langenbach C. Misoprostol in preventing postpartum hemorrhage: A meta-analysis. Int J Gynaecol Obstet. 2006;92(1):10-8.
Smith JM, Baawo SD, Subah M, Sirtor-Gbassie V, Howe CJ, Ishola G, et al. Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia. BMC Pregnancy Childbirth. 2014;14(1):1-10.
Diadhiou M, Dieng T, Ortiz C, Mall I, Dione D, Sloan NL. Introduction of misoprostol for prevention of postpartum hemorrhage at the community level in Senegal. Int J Gynaecol Obstet. 2011;115(3):251-5.
Mobeen N, Durocher J, Zuberi NF, Jahan N, Blum J, Wasim S, et al. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG. 2011;118(3):353-61.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Academic International Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
